IMBRUVICA 140 mg, 280 mg, 420 mg and 560 mg film-coated tablets

Company:
Janssen Sciences Ireland (a Johnson & Johnson Company)
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may not be renewed (A)
Active Ingredient(s):
Ibrutinib
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/14/945/007

140 milligram(s)

L01EL01

Film-coated tablet

EU/1/14/945/009

280 milligram(s)

L01EL01

Film-coated tablet

EU/1/14/945/011

420 milligram(s)

L01EL01

Film-coated tablet

EU/1/14/945/012

560 milligram(s)

L01EL01

Film-coated tablet

Address:
Janssen Sciences Ireland UC, Barnahely, Ringaskiddy, IRL - Co. Cork P43 FA46
Medical Information E-mail:
medinfo@its.jnj.com
Telephone:
+353 1 4665200
Website:
https://innovativemedicine.jnj.com/ireland/
Medical Information Direct Line:
1800 709 122

Address: